Vaccinations

Pfizer COVID tracking confirms safety for kids, heart issues extremely rare.

Fri, 2023-05-26 11:36 — mike kraft

Pfizer COVID vaccine tracking confirms safety in kids, with myocarditis, pericarditis rare CIDRAP

Monitoring of Pfizer/BioNTech COVID-19 vaccine safety among more than 3 million US children aged 5 to 17 years flagged just 2 of 20 health outcomes among 12- to 17-year-olds—myocarditis and pericarditis, which were rare.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Pfizer COVID tracking confirms safety for kids, heart issues extremely rare.
Log in or register to post comments

EU, Pfizer/BioNTech agree to cut COVID vaccine purchases

Fri, 2023-05-26 11:29 — mike kraft

EU, Pfizer/BioNTech announce amendment to COVID vaccine contract The European Union and drugmakers Pfizer and BioNTech said on Friday they had reached a deal to amend a COVID-19 vaccine contract, cutting the number the EU must buy and pushing the delivery deadline to 2026. Maggie Fick Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU, Pfizer/BioNTech agree to cut COVID vaccine purchases
Log in or register to post comments

White House ends COVID vaccine requirement for federal workers and air travel

Tue, 2023-05-09 17:37 — mike kraft

Biden drops COVID-19 vaccine requirement for federal workers, air travel - UPI.com The White House on Tuesday announced it is ending its COVID-19 vaccination requirements for federal workers and air travel starting Friday. UPI

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about White House ends COVID vaccine requirement for federal workers and air travel
Log in or register to post comments

China's CanSinoBIO's inhaled COVID booster reported stronger against BA.1 Omicron subvariant than Sinovac shot

Tue, 2023-05-09 10:21 — mike kraft

CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level dropped in months, clinical trial data showed. Reuters R

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

A better approach to pursuade parents to vaccinate kids against Covid

Fri, 2023-05-05 17:26 — mike kraft

Some messages more likely to sway parents to vaccinate kids against COVID, survey finds More parents were very likely to vaccinate their kids after reading messages saying that other trusted parents have done so or that the vaccine is safe. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about A better approach to pursuade parents to vaccinate kids against Covid
Log in or register to post comments

Analysis: Failures in achieving COVID-19 vaccine equity

Fri, 2023-05-05 17:11 — mike kraft

Cascading failures in COVID-19 vaccine equity Ethical analysis should encompass upstream decisions and their downstream consequences Science

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis: Failures in achieving COVID-19 vaccine equity
Log in or register to post comments

WHO releases strategy paper on COVID disease management and long-term disease prevention

Thu, 2023-05-04 10:55 — mike kraft

From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic The updated two-year strategy builds on the objectives of the 2022 SPRP and supports countries as they are working to transition their critical emergency response activities to longer-term sustained COVID-19 disease prevention, control and management.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about WHO releases strategy paper on COVID disease management and long-term disease prevention
Log in or register to post comments

Bivalent COVID vaccine shows good Omicron protection while older version wanes --studies

Wed, 2023-05-03 18:25 — mike kraft

Bivalent COVID vaccine shows good Omicron protection while older version wanes CIDRAP

Two studies published today measure the vaccine effectiveness (VE) of COVID-19 vaccines against laboratory-confirmed Omicron variant and subvariants and symptomatic disease. Vaccines that target the newer variants performed well, but primary vaccines offered rapidly waning protection from SARS-CoV-2 infections in the post-Omicron era.

Country / Region Tags:

General Topic Tags: